HROW FY 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$272M+36.4% YoY

Gross Profit

$204M75.1% margin

Operating Income

$31M11.2% margin

Net Income

-$5M-1.9% margin

EPS (Diluted)

$-0.14

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$43M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$399M

Total Liabilities

$347M

Stockholders' Equity

$52M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$272M	$200M	+36.4%
Gross Profit	$204M	$150M	+35.9%
Operating Income	$31M	$9M	+245.9%
Net Income	-$5M	-$17M	+70.6%